cjc-1295/ ipamorelin CJC1295 + – Peptides Collective CJC-1295 (Mod GRF 1-29) &

Ipamorelin is a selective growth hormone secretagogue that amplifies the GH pulse initiated by Tesamorelin without the cortisol spike or appetite stimulation seen with older peptides in its class

Both classes of antipsychotic medications have a number of side effects that include motor dysfunction (dyskinesia), obesity, and cardiovascular disease, as well as some endocrine abnormalities (for review, see Young et al., 2015)

By week 12, most users on the combination report 15 to 20 percent body weight reduction

The table and notes below describe what was reported in studied settings

Sermorelin has none of that visceral-fat-specific evidence base

The Microdose Glp1 Protocol starts at $129/mo